Cardiology Review®, October 2020

The risk of VTE is increased in both hospitalized and non-hospitalized COVID-19 patients.

This decrease in hospital admissions had no association with regional prevalence of COVID-19.

Individuals in vulnerable populations had a higher proportion and odds of not being vaccinated within the past year.

Ustekinumab should be prescribed cautiously to those at high cardiovascular risk.

Lanthanum is commonly prescribed to CKD patients to help reduce the risk of bone and cardiovascular disease.

Investigators report on a post-hoc analysis of the EMPA-REG OUTCOME trial that assesses the efficacy of the SGLT-2 inhibitor in patients with obstructive sleep apnea.

Approximately 11.7% of nearly 90,000 hospitalized patients with confirmed influenza suffered from an acute cardiovascular event.